vaccine

In the United States, the promise of a vaccine for the coronavirus is hampered by a vexing epidemic that long...

The country's top infectious disease expert said he's "cautiously optimistic" that researchers will develop a COVID-19 vaccine.

Early evidence that any vaccine works would lead to political pressure from the administration for emergency approval by the FDA.

Historically, racial and ethnic miniorities have been less likely to be included in clinical trials for disease treatment.

UCLA researchers found that the antibodies against SARS-CoV-2 decreased by half every 73 days.

Kaiser Health News provides a rundown of the vaccine candidates that are furthest along in the clinical phases.

A COVID-19 vaccine will have an actual price tag. And given the prevailing business-centric model of American drug pricing, it...

The two pieces of legislation are sponsored by Representatives Jan Schakowsky and Lloyd Doggett.

It is likely we'll eventually have a coronavirus vaccine ? but perhaps not as quickly as some expect.

To determine whether a vaccine prevents disease, the study's subjects need to be exposed to the pathogen as it circulates...

The billionaire surgeon-entrepreneur details his plans to use his considerable resources to combat COVID-19.

For-profit companies that typically pay $50 per donation of plasma used in other lifesaving therapies are advertising aggressively ? and...